Filing Flows

Filing Flows › Conmed (CNMD) › Recalls, complaints & regulation

Conmed (CNMD): recalls and clinical trials

Conmed (CNMD) beyond its filings: 12 recalls in the last 12 months (13 in five years, 0 Class I); 2 active clinical trials.

Latest recalls

Conmed's latest quarter

Conmed, Q3 2026: revenue $336M (-0.7% year over year), operating margin 11.1%, net earnings $19.8M, operating cash flow $49.4M. The chart follows the revenue to costs, profit and cash.

Questions

Has Conmed had any recalls?

13 recalls on file over five years from the FDA, CPSC and NHTSA; 12 in the last 12 months.

How many clinical trials does Conmed have?

2 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.